Interesting facts
Interesting Facts about Cyclopentyl N-[3-[[2-Methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate
Cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate is a fascinating compound, primarily due to its complex structure and potential applications in medicinal chemistry. Here are some engaging points to consider:
- Therapeutic Potential: This compound contains both indole and carbamate functional groups, which have been shown to possess various biological activities. Researchers are particularly interested in its potential as a drug candidate due to its unique properties.
- Targeting Mechanisms: The sulfonamide moiety within the compound suggests a possible mechanism for interaction with specific biological pathways. Compounds like this often target diseases by inhibiting specific enzymes or receptors.
- Structure-Activity Relationship (SAR): The intricate design of cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate makes it an excellent subject for SAR studies, which aim to optimize pharmacological properties by modifying chemical structures.
- Research and Development: Ongoing research in medicinal chemistry and pharmacology explores the compound's efficacy and safety profiles. Such investigations are foundational for transitioning compounds from the lab to clinical applications.
- Multifunctionality: Its diverse functional groups allow for the potential to fine-tune the compound's characteristics, making it versatile for various applications, including anti-cancer, anti-inflammatory, and anti-viral therapies.
Overall, cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate not only represents the elegance of organic synthesis but also epitomizes the exciting frontier of drug discovery and development. As we delve deeper, the possibilities this compound holds could pave the way for innovative treatments and therapies.
Synonyms
zafirlukast
107753-78-6
Accolate
Olmoran
ICI-204219
Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate
Accoleit
ICI 204,219
ICI 204219
Cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate
UNII-XZ629S5L50
DTXSID5023746
CHEBI:10100
XZ629S5L50
MFCD00864775
CHEMBL603
ICI-204,219
4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide
DTXCID303746
Aeronix
NCGC00164547-01
NCGC00164547-06
ZAFIRLUKAST (MART.)
ZAFIRLUKAST [MART.]
cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate
Vanticon
Zafirst
Respix
cyclopentyl 3-(2-methoxy-4-(o-tolylsulfonylcarbamoyl)benzyl)-1-methyl-1H-indol-5-ylcarbamate
cyclopentyl 3-[2-methoxy-4-[(o-tolylsulfonyl)carbamoyl]benzyl]-1-methylindole-5-carbamate
Accolate (TN)
CARBAMIC ACID, (3-((2-METHOXY-4-(((2-METHYLPHENYL)SULFONYL)AMINO)CARBONYL)PHENYL)METHYL)-1-METHYL-1H-INDOL-5-YL)-, CYCLOPENTYL ESTER
Cyclopentyl 3-{2-methoxy-4-[(o-tolylsulfonyl)carbamoyl]benzyl}-1-methyl-1H-indol-5-ylcarbamate
cyclopentyl N-{3-[(2-methoxy-4-{[(2-methylbenzene)sulfonyl]carbamoyl}phenyl)methyl]-1-methyl-1H-indol-5-yl}carbamate
N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic Acid Cyclopentyl Ester
SMR000466316
CAS-107753-78-6
SR-01000759386
zafirlukastum
Zafirlukast (JAN/USAN/INN)
Zafirlukast [USAN:INN:BAN]
Zafirlukast Tablets
cyclopentyl 3-(2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl)-1-methyl-1H-indol-5-ylcarbamate
ZLK
4-(5-cyclopentyloxycarbonylamino-2-methylindol-3-yl-methyl)-3-methoxy-N-O-tolylsulfonylbenzamide
Zafirlukast(Accolate)
Zafirlukast (Accolate)
Zafirlukast (Standard)
CPD000466316
ZAFIRLUKAST [MI]
ZAFIRLUKAST [INN]
ZAFIRLUKAST [JAN]
ZAFIRLUKAST [USAN]
ZAFIRLUKAST [VANDF]
SCHEMBL4175
ZAFIRLUKAST [WHO-DD]
Carbamic acid, (3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, cyclopentyl ester
cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate
MLS000759421
MLS001424064
MLS006011771
BIDD:GT0267
GTPL3322
Zafirlukast - Bio-X trade mark
Zafirlukast, >=98% (HPLC)
R03DC01
ZAFIRLUKAST [ORANGE BOOK]
YEEZWCHGZNKEEK-UHFFFAOYSA-N
HMS2051F12
HMS2089J10
HMS3393F12
HMS3650A04
HMS3655E13
HMS3713J08
HMS3745K03
BCP05226
SYB17418
Tox21_112176
BDBM50009073
HY-17492R
s1633
STK646780
AKOS005577888
Tox21_112176_1
AC-9018
CCG-101025
DB00549
FZ28747
NC00275
SB19079
NCGC00164547-02
NCGC00164547-03
NCGC00164547-04
NCGC00164547-05
NCGC00164547-11
AS-12943
BZ164562
cyclopentyl (1-methyl-3-{[2-(methyloxy)-4-({[(2-methylphenyl)sulfonyl]amino}carbonyl)phenyl]methyl}-1H-indol-5-yl)carbamate
cyclopentyl [3-(2-methoxy-4-{[(2-methylphenyl)sulfonyl]carbamoyl}benzyl)-1-methyl-1H-indol-5-yl]carbamate
cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate
HY-17492
MLS000759421-02
NS00068414
SW197655-3
Z0029
C07206
D00411
D92802
EN300-123042
AB00639922-06
AB00639922-08
AB00639922_09
L001011
Q928378
SR-01000759386-4
SR-01000759386-5
SR-01000759386-9
BRD-K71289571-001-06-4
BRD-K71289571-001-11-4
Z1546616205
Cyclopentyl 3-(2-methoxy-4-((2-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate
[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic acid cyclopentyl ester;IC I-2204219;Accolate
[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic acid cyclopentyl ester;IC I-2204219;Accolate
Carbamic acid, N-[3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]-, cyclopentyl ester
Carbamic Acid,(3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, Cyclopentyl Ester
Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)-carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate
cyclopentyl N-[3-({2-methoxy-4-[(2-methylbenzenesulfonyl)carbamoyl]phenyl}methyl)-1-methyl-1H-indol-5-yl]carbamate
Cyclopentyl N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamate
Solubility of Cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate
The solubility of the compound C32H32N2O6S, known as cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate, can be influenced by several factors, making it a fascinating subject in the study of chemical compounds. Understanding solubility is crucial as it impacts the compound's potential applications in various fields. Here are some key points to consider:
While there is no universal solubility rule, one can deduce that \"like dissolves like\"; thus, interactions between the functional groups and the solvent will ultimately dictate the compound's solubility behaviour. To summarize, the solubility of cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate is likely to be a balance of polar and non-polar characteristics, and comprehensive experimentation is necessary for precise solubility data.